US2018153949A1PendingUtilityA1

Composition, containing quisaqualis indica extract, for preventing or treating prostatic hyperplasia

Assignee: IAC IN NAT UNIV CHUNGNAMPriority: May 18, 2015Filed: May 3, 2016Published: Jun 7, 2018
Est. expiryMay 18, 2035(~8.8 yrs left)· nominal 20-yr term from priority
Inventors:Hyo Jung Kwon
A61P 13/08A61K 36/185A61K 2236/333A61K 2236/331
39
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A pharmaceutical composition comprises a Quisaqualis indica extract as an active ingredient, for preventing or treating prostatic hyperplasia, and may also be used in a food composition. The Quisaqualis indica extract may be used to treat and prevent prostatic hyperplasia by exhibiting effects of a reduction in prostate weight, a reduction in DHT as a prostatic hyperplasia inducing factor, and a reduction in prostate epithelial cell hyperplasia.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A pharmaceutical composition comprising a  Quisaqualis indica  extract as an active ingredient for preventing or treating prostatic hyperplasia. 
     
     
         2 . The composition according to  claim 1 , wherein the  Quisqualis indica  extract is extracted with water, lower alcohol having 1 to 4 carbon atoms, or their mixed solvent. 
     
     
         3 . The composition according to  claim 1 , wherein the  Quisqualis indica  extract has effects on the reduction of prostate weight, dihydrotestosterone (DHT) that is a factor causing prostatic hyperplasia, and prostate epithelial hyperplasia. 
     
     
         4 . A food composition comprising a  Quisaqualis indica  extract as an active ingredient for preventing or improving prostatic hyperplasia.

Join the waitlist — get patent alerts

Track US2018153949A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.